CHEK2 1100delC mutation is frequent among Russian breast cancer patients

被引：28
|
作者：
Chekmariova, Elena V.
Sokolenko, Anna P.
Buslov, Konstantin G.
Iyevleva, Aglaya G.
Ulibina, Yulia M.
Rozanov, Maxim E.
Mitiushkina, Natalia V.
Togo, Alexandr V.
Matsko, Dmitry E.
Voskresenskiy, Dmitry A.
Chagunava, Oleg L.
Devilee, Peter
Cornelisse, Cees
Semiglazov, Vladimir F.
Imyanitov, Evgeny N.
机构：
[1] NN Petrov Inst Oncol, St Petersburg 197758, Russia
[2] Ctr Mammol, St Petersburg, Russia
[3] Leiden Univ, Med Ctr, Leiden, Netherlands
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2006年 / 100卷 / 01期
基金：
俄罗斯基础研究基金会;
关键词：
CHEK2; 1100delC; mutation; breast cancer predisposition; elderly;
D O I：
10.1007/s10549-006-9227-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
This study was aimed to assess the role of CHEK2 1100delC mutation in breast cancer (BC) predisposition in Russia. The 1100delC allele was detected in 14/660 (2.1%) unilateral BC cases and in 8/155 (5.2%) patients with the bilateral form of the disease, but only in 1/448 (0.2%) middle-aged control females and in none of 373 elderly tumor-free women. The obtained data point at potentially high clinical relevance of CHEK2 1100delC testing in females of Russian origin and warrant similar case-control studies in ethnically and geographically related regions, especially in Ukraine, Belarus and Baltic countries.
引用
收藏
页码：99 / 102
页数：4
相关论文
共 50 条
  • [41] Low frequency of CHEK2 1100delC mutation in breast cancer patients and hereditary breast cancer families in the Czech Republic.
    Kleibl, Z
    Novotny, J
    Pohlreich, P
    Zikan, M
    Cinek, P
    Janatova, M
    Petruzelka, L
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 844S - 844S
  • [42] CHEK2*1100delC homozygosity is associated with a high breast cancer risk in women
    Adank, Muriel A.
    Jonker, Marianne A.
    Kluijt, Irma
    van Mil, Saskia E.
    Oldenburg, Rogier A.
    Mooi, Wolter J.
    Hogervorst, Frans B. L.
    van den Ouweland, Ans M. W.
    Gille, Johan J. P.
    Schmidt, Marjanka K.
    van der Vaart, Aad W.
    Meijers-Heijboer, Hanne
    Waisfisz, Quinten
    JOURNAL OF MEDICAL GENETICS, 2011, 48 (12) : 860 - 863
  • [43] Colorectal cancer risk associated with the CHEK2 1100delC variant
    Katona, Bryson W.
    Yang, Yu-Xiao
    EUROPEAN JOURNAL OF CANCER, 2017, 83 : 103 - 105
  • [44] Increased CHEK2 1100delC genotype frequency (also) in unselected breast cancer patients.
    De Jong, MM
    Van der Graaf, WTA
    Nolte, IM
    Meerman, GJT
    Oosterwijk, JC
    Van der Steege, G
    Boezen, M
    Schaapveld, M
    Kleibeuker, JH
    De Vries, EGE
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 844S - 844S
  • [45] The CHEK2*1100delC mutation has no major contribution in oesophageal carcinogenesis
    Koppert, LB
    Schutte, M
    Abbou, M
    Tilanus, HW
    Dinjens, WNM
    BRITISH JOURNAL OF CANCER, 2004, 90 (04) : 888 - 891
  • [46] Absence of CHEK2 1100delC mutation in familial breast cancer cases from a South American population
    Patricio González-Hormazábal
    Víctor G. Castro
    Rafael Blanco
    Fernando Gómez
    Octavio Peralta
    Enrique Waugh
    Teresa Bravo
    Jose M. Reyes
    Lilian Jara
    Breast Cancer Research and Treatment, 2008, 110 : 543 - 545
  • [47] Breast cancer survival and tumor characteristics in premenopausal women carrying the CHEK2*1100delC germline mutation
    Schmidt, Marjanka K.
    Tollenaar, Rob A. E. M.
    de Kemp, Sanne R.
    Broeks, Annegien
    Cornelisse, Cees J.
    Smit, Vincent T. H. B. M.
    Peterse, Johannes L.
    van Leeuwen, Flora E.
    Van't Veer, Laura J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (01) : 64 - 69
  • [48] Absence of CHEK2 1100delC mutation in familial breast cancer cases from a South American population
    Gonzalez-Hormazabal, Patricio
    Castro, Victor G.
    Blanco, Rafael
    Gomez, Fernando
    Peralta, Octavio
    Waugh, Enrique
    Bravo, Teresa
    Reyes, Jose M.
    Jara, Lilian
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 110 (03) : 543 - 545
  • [49] CHEK2* 1100delC screening of Asian women with a family history of breast cancer is unwarranted
    Lee, Ann S. G.
    Ang, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (14) : 2419 - 2419
  • [50] The CHEK2 1100delC mutation is not present in Korean patients with breast cancer tested for BRCA1 and BRCA2 mutation
    Choi, D. H.
    Cho, H. Y.
    Lee, M. H.
    Park, H. S.
    Ahn, S. H.
    Haffty, B. G.
    BREAST, 2007, 16 : S14 - S14
12345